A detailed history of High Net Worth Advisory Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 34,962 shares of PFE stock, worth $995,018. This represents 0.28% of its overall portfolio holdings.

Number of Shares
34,962
Previous 18,646 87.5%
Holding current value
$995,018
Previous $521,000 94.05%
% of portfolio
0.28%
Previous 0.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$27.7 - $31.39 $451,953 - $512,159
16,316 Added 87.5%
34,962 $1.01 Million
Q2 2024

Jul 17, 2024

SELL
$25.26 - $29.6 $160,527 - $188,108
-6,355 Reduced 25.42%
18,646 $521,000
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $15,534 - $17,838
600 Added 2.46%
25,001 $693,000
Q4 2023

Jan 08, 2024

SELL
$26.13 - $33.94 $372,065 - $483,271
-14,239 Reduced 36.85%
24,401 $702,000
Q3 2023

Oct 05, 2023

SELL
$32.09 - $37.51 $52,146 - $60,953
-1,625 Reduced 4.04%
38,640 $1.28 Million
Q2 2023

Jul 07, 2023

BUY
$36.12 - $41.79 $93,009 - $107,609
2,575 Added 6.83%
40,265 $1.48 Million
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $122,148 - $159,019
-3,101 Reduced 7.6%
37,690 $1.54 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $63,752 - $83,221
-1,527 Reduced 3.61%
40,791 $2.09 Million
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $13,128 - $16,026
-300 Reduced 0.7%
42,318 $1.85 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $91,617 - $108,629
1,969 Added 4.84%
42,618 $2.23 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $96,624 - $119,729
2,112 Added 5.48%
40,649 $2.1 Million
Q4 2021

Apr 27, 2022

BUY
$41.32 - $61.25 $1.59 Million - $2.36 Million
38,537 New
38,537 $2.15 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track High Net Worth Advisory Group LLC Portfolio

Follow High Net Worth Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Net Worth Advisory Group LLC with notifications on news.